What is a stock summary page? Click here for an overview.
Business Description
Galecto Inc
NAICS : 541714
SIC : 2834
ISIN : US36322Q1076
Share Class Description:
GLTO: Ordinary SharesDescription
Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 194.18 | |||||
| Equity-to-Asset | 0.92 | |||||
| Debt-to-Equity | 0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 29.1 | |||||
| 3-Year EPS without NRI Growth Rate | 30 | |||||
| 3-Year FCF Growth Rate | 32.4 | |||||
| 3-Year Book Growth Rate | -54.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | -20.62 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 26.98 | |||||
| 9-Day RSI | 32.84 | |||||
| 14-Day RSI | 35.79 | |||||
| 3-1 Month Momentum % | -28.6 | |||||
| 6-1 Month Momentum % | -65.15 | |||||
| 12-1 Month Momentum % | -77.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 14.07 | |||||
| Quick Ratio | 14.07 | |||||
| Cash Ratio | 11.84 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.3 | |||||
| Shareholder Yield % | 12.62 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -88.71 | |||||
| ROA % | -77.39 | |||||
| ROIC % | -622.17 | |||||
| 3-Year ROIIC % | -187.75 | |||||
| ROC (Joel Greenblatt) % | -7027.06 | |||||
| ROCE % | -87.97 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.23 | |||||
| Price-to-Tangible-Book | 0.23 | |||||
| EV-to-EBIT | 0.42 | |||||
| EV-to-Forward-EBIT | -0.19 | |||||
| EV-to-EBITDA | 0.43 | |||||
| EV-to-Forward-EBITDA | -0.17 | |||||
| EV-to-FCF | 0.48 | |||||
| Price-to-Net-Current-Asset-Value | 0.24 | |||||
| Price-to-Net-Cash | 0.26 | |||||
| Earnings Yield (Greenblatt) % | 238.1 | |||||
| FCF Yield % | -554.42 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GLTO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Galecto Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -18.62 | ||
| Beta | 1.45 | ||
| 3-Year Sharpe Ratio | -0.22 | ||
| 3-Year Sortino Ratio | -0.32 | ||
| Volatility % | 57.31 | ||
| 14-Day RSI | 35.79 | ||
| 14-Day ATR ($) | 0.613246 | ||
| 20-Day SMA ($) | 3.995 | ||
| 12-1 Month Momentum % | -77.7 | ||
| 52-Week Range ($) | 2.5 - 19.75 | ||
| Shares Outstanding (Mil) | 1.32 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Galecto Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Galecto Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Galecto Inc Frequently Asked Questions
What is Galecto Inc(GLTO)'s stock price today?
The current price of GLTO is $2.54. The 52 week high of GLTO is $19.75 and 52 week low is $2.50.
When is next earnings date of Galecto Inc(GLTO)?
The next earnings date of Galecto Inc(GLTO) is 2025-04-29 Est..
Does Galecto Inc(GLTO) pay dividends? If so, how much?
Galecto Inc(GLTO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers